Great_老虎社区_美港股上老虎

Leo72
2021-11-23

Great

Progenity strengthens liquidity position capable enough to achieve R&D milestones through 2022

Progenity(NASDAQ:PROG)strengthened its liquidity position as it reported ~$44M in warrant exercises

Progenity strengthens liquidity position capable enough to achieve R&D milestones through 2022

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":875578477,"tweetId":"875578477","gmtCreate":1637675560789,"gmtModify":1637675560789,"author":{"id":3580610192874303,"idStr":"3580610192874303","authorId":3580610192874303,"authorIdStr":"3580610192874303","name":"Leo72","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Great</p></body></html>","htmlText":"<html><head></head><body><p>Great</p></body></html>","text":"Great","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/875578477","repostId":1188126714,"repostType":4,"repost":{"id":"1188126714","kind":"news","pubTimestamp":1637675025,"share":"https://www.laohu8.com/m/news/1188126714?lang=&edition=full","pubTime":"2021-11-23 21:43","market":"us","language":"en","title":"Progenity strengthens liquidity position capable enough to achieve R&D milestones through 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1188126714","media":"seekingalpha","summary":"Progenity(NASDAQ:PROG)strengthened its liquidity position as it reported ~$44M in warrant exercises ","content":"<p>Progenity(NASDAQ:PROG)strengthened&nbsp;its liquidity position as it reported ~$44M in warrant exercises to date&nbsp;during Q4.</p>\n<p>Through an&nbsp;exchange transaction in Q4, the company reduced by 38% the principal amount of its convertible senior notes due 2025 held by non-affiliates, with the majority of the remaining balance held by an affiliated holder, Athyrium Capital Management.</p>\n<p>The current liquidity position provides&nbsp;runway to achieve critical research and development milestones through 2022.</p>\n<p>\"In a very short period of time, we’ve simplified our operations and focused our capital allocation to transform Progenity into a biotherapeutics company. We expect further improvement in operating expenditures as we continue to execute our transformation and focus on expediting development of our gastrointestinal health and oral biotherapeutics programs,\" CEO Adi Mohanty commented.</p>\n<p>Shares&nbsp;trading 3.8% down premarket</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Progenity strengthens liquidity position capable enough to achieve R&D milestones through 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProgenity strengthens liquidity position capable enough to achieve R&D milestones through 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 21:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3773706-progenity-strengthens-liquidity-position-capable-enough-to-achieve-rd-milestones-through-2022><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Progenity(NASDAQ:PROG)strengthened its liquidity position as it reported ~$44M in warrant exercises to date during Q4.\nThrough an exchange transaction in Q4, the company reduced by 38% the principal ...</p>\n\n<a href=\"https://seekingalpha.com/news/3773706-progenity-strengthens-liquidity-position-capable-enough-to-achieve-rd-milestones-through-2022\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3773706-progenity-strengthens-liquidity-position-capable-enough-to-achieve-rd-milestones-through-2022","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1188126714","content_text":"Progenity(NASDAQ:PROG)strengthened its liquidity position as it reported ~$44M in warrant exercises to date during Q4.\nThrough an exchange transaction in Q4, the company reduced by 38% the principal amount of its convertible senior notes due 2025 held by non-affiliates, with the majority of the remaining balance held by an affiliated holder, Athyrium Capital Management.\nThe current liquidity position provides runway to achieve critical research and development milestones through 2022.\n\"In a very short period of time, we’ve simplified our operations and focused our capital allocation to transform Progenity into a biotherapeutics company. We expect further improvement in operating expenditures as we continue to execute our transformation and focus on expediting development of our gastrointestinal health and oral biotherapeutics programs,\" CEO Adi Mohanty commented.\nShares trading 3.8% down premarket","news_type":1},"isVote":1,"tweetType":1,"viewCount":605,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Progenity strengthens liquidity position capable enough to achieve R&D milestones through 2022

评论（2）

热议股票